Eli Casdin

Eli Casdin serves as the Chief Investment Officer at Casdin Capital, LLC since November 2011 and holds various board member positions, including the New York Genome Center and Standard BioTools. As of April 2021, Eli Casdin is a board member at The Rockefeller University, and also contributes to Columbia University School of General Studies as a member of the Board of Visitors. Additional board memberships include GeneDx, Prominex Inc., Genomatica, and previously Tenaya Therapeutics. Eli Casdin earned an MBA in Finance - Accounting from Columbia Business School and a Bachelor of Science from Columbia University, along with prior education at the University of Vermont and Riverdale Country School.